
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by: investing in research and development collaborating...
Developing and commercializing therapies that improve the lives of people with nervous system disorders,including multiple sclerosis (ms),spinal cord injury (sci),stroke and epilepsy. also developing a therapeutic approach for chronic heart failure.
Acorda therapeutics, inc operates in the Biotechnology research industry.
Acorda therapeutics, inc's revenue is 11m - 100m
Acorda therapeutics, inc has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.